Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1β in vascular smooth muscle cells: Interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-κB and Ets transcription factors

Biochemical Journal

Volumn 368, Issue 2, 2002, Pages 415-424

  Antonio, Valérie ^a   Brouillet, Arthur ^a   Janvier, Brigitte ^a   Monne, Claire ^a   Bereziat, Gilbert ^a   Andreani, Marise ^a   Raymondjean, Michel ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Atherosclerosis; Gene expression; Inflammation; Promoter; Ras pathway

Indexed keywords

CELLS; DISEASES; ELECTROPHORESIS; GENES; MUSCLE; MUTAGENESIS;

INFLAMMATORY PROCESS;

ENZYMES;

CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; MITHRAMYCIN; PHOSPHOLIPASE A2; RAS PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CATALYSIS; CELL PROLIFERATION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

ANIMALS; ARTERIOSCLEROSIS; BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PHOSPHOLIPASES A; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RAS PROTEINS; RATS; RATS, WISTAR; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0036904881     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020658     Document Type: Article

References (38)

1. Ross, R. (1999) Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 340, 115-126
2. Keaney, Jr, J. F. and Vita, J. A. (2002) The value of inflammation for predicting unstable angina. N. Engl. J. Med. 347, 55-57
3. Shapiro, L. and Gelfand, J. A. (1993) Cytokines and sepsis: Pathophysiology and therapy. New Horiz. 1, 13-22
4. Nakano, T., Ohara, O., Teraoka, H. and Arita, H. (1990) Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 261, 171-174
5. Hurt-Camejo, E., Camejo, G., Peilot, H., Oorni, K. and Kovanen, P. (2001) Phospholipase A(2) in vascular disease. Circ. Res. 89, 298-304
6. Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K. and Kudo, I. (1997) Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225-283
7. Schiering, A., Menschikowski, M., Mueller, E. and Jaross, W. (1999) Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis. Atherosclerosis 144, 73-78
8. Ivandic, B., Castellani, L. W., Wang, X. P., Qiao, J. H., Mehrabian, M., Navab, M., Fogelman, A. M., Grass, D. S., Swanson, M. E., de Beer, M. C. et al. (1999) Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 19, 1284-1290
9. Ishizaki, J., Ohara, O., Nakamura, E., Tamaki, M., Ono, T., Kanda, A., Yoshida, N., Teraoka, H., Tojo, H. and Okamoto, M. (1989) cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem. Biophys. Res. Commun. 162, 1030-1036
10. Kramer, R. M., Hession, C., Johansen, B., Hayes, G., McGray, P., Chow, E. P., Tizard, R. and Pepinsky, R. B. (1989) Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264, 5768-5775
11. Kusunoki, C., Satoh, S., Kobayashi, M. and Niwa, M. (1990) Structure of genomic DNA for rat platelet phospholipase A2. Biochim. Biophys. Acta 1087, 95-97
12. Seilhamer, J. J., Pruzanski, W., Vadas, P., Plant, S., Miller, J. A., Kloss, J. and Johnson, L. K. (1989) Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264, 5335-5338
13. Couturier, C., Brouillet, A., Couriaud, C., Koumanov, K., Berezial, G. and Andreani, M. (1999) Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisorne proliferator-activated receptor-mediated process. J. Biol. Chem. 274, 23085-23093
14. Couturier, C., Antonio, V., Brouillet, A., Bereziat, G., Raymondjean, M. and Andreani, M. (2000) Protein kinase A-dependent stimulation of rat type II secreted phospholipase A(2) gene transcription involves C/EBP-beta and -delta in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 2559-2565
15. Ohara, O., Ishizaki, J., Nakano, T., Arita, H. and Teraoka, H. (1990) A simple and sensitive method for determining transcription initiation site: Identification of two transcription initiation sites in rat group II phospholipase A2 gene. Nucleic Acids Res. 18, 6997-7002
16. Komada, M., Kudo, I. and Inoue, K. (1990) Structure of gene coding for rat group II phospholipase A2. Biochem. Biophys. Res. Commun. 168, 1059-1065
17. Dorsam, G., Taher, M. M., Valerie, K. C., Kuemmerle, N. B., Chan, J. C. and Franson, R. C. (2000) Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells. J. Pharmacol. Exp. Ther. 292, 271-279
18. Wasylyk, B., Hagman, J. and Gutierrez-Hartmann, A. (1998) Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 23, 213-216
19. Zhao, X., Martin, M. M. and Elton, T. S. (2001) The transcription factors Sp1 and Sp3 are required for human angiotensin II type 1 receptor gene expression in H295-R cells. Biochim. Biophys. Acta 1522, 195-206
20. Niehof, M., Manns, M. P. and Trautwein, C. (1997) CREB controls LAP/C/EBP beta transcription. Mol. Cell. Biol. 17, 3600-3613
21. Chinery, R., Brockman, J. A., Dransfield, D. T. and Coffey, R. J. (1997) Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A criticai role for protein kinase A-mediated phosphorylation of Ser299. J. Biol. Chem. 272, 30356-30361
22. Poli, V. (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273, 29279-29282
23. Karin, M. (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274, 27339-27342
24. Hoshi, S., Goto, M., Koyama, N., Nomoto, K. and Tanaka, H. (2000) Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. J. Biol. Chem. 275, 883-889
25. Walker, G., Kunz, D., Pignat, W., van den Bosch, H. and Pfeilschifter, J. (1997) Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells. Br. J. Pharmacol. 121, 787-793
26. Hultgardh-Nilsson, A., Cercek, B., Wang, J. W., Naito, S., Lovdahl, C., Sharifi, B., Forrester, J. S. and Fagin, J. A. (1996) Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ. Res. 78, 589-595
27. Goetze, S., Kintscher, U., Kaneshiro, K., Meehan, W. P., Collins, A., Fleck, E., Hsueh, W. A. and Law, R. E. (2001) TNFαlpha induces expression of transcription factors c-los, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 159, 93-101
28. Fonteh, A. N., Atsumi, G., LaPorte, T. and Chilton, F. H. (2000) Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J. Immunol. 165, 2773-2782
29. Anderson, K. M., Roshak, A., Winkler, J. D., McCord, M. and Marshall, L. A. (1997) Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem. 272, 30504-30511
30. Courey, A. J. and Tjian, R. (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898
31. Massaad, C., Paradon, M., Jacques, C., Salvat, C., Berezial, G., Berenbaum, F. and Olivier, J. L. (2000) Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1beta. Role of C/EBP factors. J. Biol. Chem. 275, 22686-22694
32. Xia, L. and Zhang, Y. (2001) Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene 268, 77-85
33. Seto, E., Lewis, B. and Shenk, T. (1993) Interaction between transcription factors Sp1 and YY1. Nature (London) 365, 462-464
34. Yet, S. F., Folta, S. C., Jain, M. K., Hsieh, C. M., Maemura, K., Layne, M. D., Zhang, D., Marria, P. B., Yoshizumi, M., Chin, M. T. et al. (1998) Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene. Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J. Biol. Chem. 273, 10530-10537
35. Ribault, S., Neuville, P., Mechine-Neuville, A., Auge, F., Parlakian, A., Gabbiani, G., Paulin, D. and Calenda, V. (2001) Chimeric smooth muscle-specific enhancer/promoters: Valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ. Res. 88, 468-475
36. Raymondjean, M., Cereghini, S. and Yaniv, M. (1988) Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells. Proc. Natl. Acad. Sci. U.S.A. 85, 757-761
37. Rossi, P., Karsenty, G., Roberts, A. B., Roche, N. S., Sporn, M. B. and de Crombrugghe, B. (1988) A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 52, 405-414
38. Yant, S. R., Zhu, W., Millinoff, D., Slightom, J. L., Goodman, M. and Gumucio, D. L. (1995) High affinity YY1 binding motifs: Identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res. 23, 4353-4362